Heterogeneity in Long-Term Outcomes for R-ISS Stage II in Patients With Newly Diagnosed Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Haematologica
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Heterogeneity in long term outcomes for R-ISS stage II in newly diagnosed multiple myeloma patients
Haematologica 2022 Sep 29;[EPub Ahead of Print], A Schavgoulidze, V Lauwers-Cances, A Perrot, T Cazaubiel, ML Chretien, P Moreau, T Facon, X Leleu, L Karlin, AM Stoppa, O Decaux, K Belhadj, B Arnulf, M Mohty, CM Ariette, C Fohrer-Sonntag, P Lenain, JP Marolleau, M Tiab, C Araujo, F Orsini-Piocelle, A Jaccard, M Roussel, L Benboubker, JR Eveillard, M Dib, M Divoux, M Attal, H Avet-Loiseau, J CorreFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.